Canopy Growth Has Begun Lobbying In The US. What Is The Company Up To In New York?

Canopy Growth Has Begun Lobbying In The US. What Is The Company Up To In New York?

Canopy Growth, a Canadian cannabis company and one of the world’s largest, is expanding its lobbying efforts in the United States. Check out awesome wedding cake strain in our space monkey meds category

Cannabis Wire first reported the company’s US lobbying efforts last week, noting that California-based firm Platinum Advisors registered on behalf of the company. In Congress, Canopy Growth is focused on the SAFE Banking Act, the STATES Act, and “cannabis and hemp agricultural issues,” according to lobbying disclosures for the spring. But its efforts aren’t limited to federal legislation.

Cannabis Wire also has donkey butter strain and has found that Canopy Growth has also been lobbying in New York state since late March. The company is in the process of setting up its multi-million dollar, 308,000 square-foot “hemp industrial park” in upstate New York, the location for which was secured in April. The company is also in the process of acquiring Acreage Holdings, which holds one of ten medical cannabis licenses in the state.

(Read Cannabis Wire’s story on Canopy’s upstate New York industrial park here).

Cozen O’Connor Public Strategies, a New York-based lobbying firm that also lists Atlanta-based medical cannabis company Surterra Holdings as a client, registered on behalf of Canopy Growth. Eight lobbyists from the company have been engaging legislators and government bodies around “cannabis/marijuana” and “legalization” in the state.